Defining Benchmarks in Bariatric Surgery

NCT ID: NCT03440138

Last Updated: 2019-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

5741 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-17

Study Completion Date

2019-09-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim: To define benchmark outcomes in minimally-invasive primary bariatric surgery.

Design: Multicenter retrospective cohort study.

Assessed outcomes: Morbidity as defined by the Clavien-Dindo classification for surgical complications, the Comprehensive Complication Index® (CCI®) at discharge, at 3 months and at latest follow-up. Evolution of body mass index (BMI) will be also analyzed.

Hospital eligibility: High volume centers (\> 200 bariatric operations per year) from at least three continents, maintaining a prospective database, as well as having published previously critically on their outcome.

Study population: Adult patients who underwent primary minimally invasive (laparoscopic / robotic) Roux-en-Y gastric bypass or sleeve gastrectomy from 1st of June 2012 to 31st of May 2017.

Patient Exclusion criteria: detailed later.

Data collection Deadline: 1st September 2017 - 30 April 2018

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background With the growing complexity and cost of modern surgical practice, quality assessment becomes mandatory. The notion of quality and quality assessment is widely recognized and used in the world of business and manufacturing. A possible tool of quality assessment is benchmarking. Benchmarking is a process of measuring performance by comparison to the outcomes achieved by the best "service provider" in a specific domain. Usually, a benchmark describes the ''best possible'' outcome of a benchmarking subject to whom comparison can be performed. In the surgical community, however, such benchmarks - best possible outcomes - for specific procedures, not just the pooled overall performance, are lacking.

In 2016, a first landmark study defining benchmark outcomes for liver resection was published in Annals of Surgery by a group of international authors invited and guided by our department. More recently, further surgical outcomes (liver transplantation, minimally invasive esophagectomy) have been benchmarked and have been accepted for publication.

Since laparoscopic bariatric surgery has become a standardized and widely performed procedure worldwide, quality assessment is of major importance. To identify the best possible outcomes (i.e. the benchmarks), data from high-volume centers (based on official IFSO criteria) in low risk patients will be analyzed. These benchmarks will serve as "optimal outcomes" for comparison with single center outcomes, high-risk patients and future developments.

Aim The primary aim is to define benchmark outcomes based on assessment of post procedural complications according to the Clavien-Dindo classification for surgical complications and the comprehensive complication index CCI™ at discharge and at 90-days. The CCI® expresses morbidity on a continuous numeric scale from 0 (no complications) to 100 (death) by weighing all postoperative complications according to the Clavien-Dindo classification for their respective severity. Secondary outcome measure are patient survival and excess BMI loss (EBMIL).

Data Security This multicenter international study is designed to harvest prospectively collected retrospective data via an encrypted (i.e. Secure Sockets Layer (SSL) protocol) online platform (https://bbenchmarks.org/) that meets Food and Drug Administration (FDA) standards and is accessible only by secured login membership.

Confidential center specific data: Centers' outcomes will be individually analyzed in a first step to screen for center-specific differences. Benchmarks will be computed from each center's results in a second step. No center-specific data will be published. Instead, all complications or adverse outcomes will be anonymously reported, as fractions of the total study population. Each center, of course, will be free to publish their own data, as they wish.

Further use of cohort data: Future studies based on the collected data may emerge from this multicenter study, such as comparing outcomes in patients with or without specific comorbidities with benchmark outcomes. For further data usage, additional ethics approval may be required.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benchmark Bariatric Surgery Roux-en-y Gastric Bypass Sleeve Gastrectomy Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

University Hospital Zurich

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

St Pierre University Hospital, Brussels, Belgium

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Sana Klinikum, Offenbach, Germany

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Complutense University of Madrid, Spain

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Musgrove Park Hospital, Taunton, UK

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

University of Gothenburg, Sweden

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

AZ Sint-Jan Hospital in Bruges, Belgium

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Bristol

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Cleveland Clinic, Weston, Florida, USA

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Oswaldo Cruz German Hospital, Sao Paolo, Brazil

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Clínica Las Condes, Santiago, Chile

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Brown University, Providence Rhode Island

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Fresno Bariatric, CA, USA

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Rijnstate Hospital, Arnhem, The Netherlands

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

CHU Nice, France

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Claraspital Basel, Switzerland

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Gastro-Obeso-Center Advanced Med Inst, Brazil

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Hospital Dipreca Santiago Región Metropolitana , Chile

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Medical University Wien, Austria

bariatric surgery (RYGB or SG)

Intervention Type PROCEDURE

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bariatric surgery (RYGB or SG)

laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy for severe obesity

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients of 18-65 years

Exclusion Criteria

* Maximum preoperative BMI of 50 kg/m2
* Primary laparoscopic/robotic proximal Roux-en-Y gastric bypass or sleeve gastrectomy
* Documented follow-up of at least 90 days


* Open surgery
* Previous intra-abdominal surgery (including previous bariatric surgery)
* Pre-operative BMI over 50 kg/m2
* Age over 65 years
* Cardiovascular disease (e.g. cardiac arrhythmia, stroke, coronary artery disease) (Hypertension is allowed)
* History of thromboembolic events and/or therapeutic anticoagulation
* Diabetes mellitus (Type I and Type II, as defined by the American Diabetes Association)
* Obstructive sleep apnea (recurrent episodes of upper airway collapse during sleep)
* Chronic obstructive pulmonary disease (FEV1/FVC\<0.7)
* Chronic kidney disease (eGFR \< 30ml/min/1.72 m2)
* Inflammatory bowel disease (ulcerative colitis, Crohn's)
* Immunosuppression therapy (e.g. steroids, calcineurin inhibitors, etc)
* Patients who underwent associated procedures (for example: cholecystectomy, hiatoplasty, liver biopsy)
* ASA score \> 2
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dr. med. Daniel Gero

UNKNOWN

Sponsor Role collaborator

Dr. med. Dimitri A. Raptis, PhD

UNKNOWN

Sponsor Role collaborator

Dr. med. Henner Schmidt

UNKNOWN

Sponsor Role collaborator

Marco Bueter

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marco Bueter

Prof. Dr. med., PhD

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Zurich

Zurich, Canton of Zurich, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Rossler F, Sapisochin G, Song G, Lin YH, Simpson MA, Hasegawa K, Laurenzi A, Sanchez Cabus S, Nunez MI, Gatti A, Beltrame MC, Slankamenac K, Greig PD, Lee SG, Chen CL, Grant DR, Pomfret EA, Kokudo N, Cherqui D, Olthoff KM, Shaked A, Garcia-Valdecasas JC, Lerut J, Troisi RI, De Santibanes M, Petrowsky H, Puhan MA, Clavien PA. Defining Benchmarks for Major Liver Surgery: A multicenter Analysis of 5202 Living Liver Donors. Ann Surg. 2016 Sep;264(3):492-500. doi: 10.1097/SLA.0000000000001849.

Reference Type BACKGROUND
PMID: 27433909 (View on PubMed)

Muller X, Marcon F, Sapisochin G, Marquez M, Dondero F, Rayar M, Doyle MMB, Callans L, Li J, Nowak G, Allard MA, Jochmans I, Jacskon K, Beltrame MC, van Reeven M, Iesari S, Cucchetti A, Sharma H, Staiger RD, Raptis DA, Petrowsky H, de Oliveira M, Hernandez-Alejandro R, Pinna AD, Lerut J, Polak WG, de Santibanes E, de Santibanes M, Cameron AM, Pirenne J, Cherqui D, Adam RA, Ericzon BG, Nashan B, Olthoff K, Shaked A, Chapman WC, Boudjema K, Soubrane O, Paugam-Burtz C, Greig PD, Grant DR, Carvalheiro A, Muiesan P, Dutkowski P, Puhan M, Clavien PA. Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results. Ann Surg. 2018 Mar;267(3):419-425. doi: 10.1097/SLA.0000000000002477.

Reference Type BACKGROUND
PMID: 28885508 (View on PubMed)

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.

Reference Type BACKGROUND
PMID: 15273542 (View on PubMed)

Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013 Jul;258(1):1-7. doi: 10.1097/SLA.0b013e318296c732.

Reference Type BACKGROUND
PMID: 23728278 (View on PubMed)

Gero D, Raptis DA, Vleeschouwers W, van Veldhuisen SL, Martin AS, Xiao Y, Galvao M, Giorgi M, Benois M, Espinoza F, Hollyman M, Lloyd A, Hosa H, Schmidt H, Garcia-Galocha JL, van de Vrande S, Chiappetta S, Menzo EL, Aboud CM, Luthy SG, Orchard P, Rothe S, Prager G, Pournaras DJ, Cohen R, Rosenthal R, Weiner R, Himpens J, Torres A, Higa K, Welbourn R, Berry M, Boza C, Iannelli A, Vithiananthan S, Ramos A, Olbers T, Sepulveda M, Hazebroek EJ, Dillemans B, Staiger RD, Puhan MA, Peterli R, Bueter M. Defining Global Benchmarks in Bariatric Surgery: A Retrospective Multicenter Analysis of Minimally Invasive Roux-en-Y Gastric Bypass and Sleeve Gastrectomy. Ann Surg. 2019 Nov;270(5):859-867. doi: 10.1097/SLA.0000000000003512.

Reference Type DERIVED
PMID: 31592894 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BASECnr_2017-01652

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bariatric Surgery for Obesity
NCT06901440 NOT_YET_RECRUITING